This review provides tentative meta-analytic evidence for the efficacy of psychoeducation in improving caregiver burden at post-treatment, and knowledge at post-treatment and follow-up. Services could consider offering psychoeducation as part of a multi-disciplinary package of care. However, more methodologically rigorous research is needed before clinical recommendations can be made with confidence.
Background: Optimal intervention for bipolar disorder (BD) is seen as a priority within early intervention psychosis services. This is the first study to explore the experience of first episode psychotic mania and its aftermath for people diagnosed with BD, and the potential implications for treatment. Method: Semi-structured interviews were conducted with 11 young adults following first episode psychotic mania and analysed using Interpretative Phenomenological Analysis (IPA). Results: Two overarching themes were identified: (i) 'Changing states of self during first episode'; (ii) 'Struggling with loss of self during episode aftermath'. Participants experienced exceptional, persecutory and angry states during psychotic mania that led to identity disruption and low feelings or depression post-episode. Some mourned the loss of their exceptional manic self, and attempted to relapse into mania, while others struggled with the loss of who they had been prior to their episode. Conclusion:Results emphasise the importance of understanding identity change during first episode psychotic mania and how that might be used to address identity disruption and low feelings during recovery. This process is likely to be pertinent to early intervention and prevention of manic relapse following first episode BD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.